N
CCRN

Nuveen’s Cross Country Healthcare CCRN Stock Holding History

Nuveen’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$958K Buy
101,949
+24,727
+32% +$221K ﹤0.01% 2599
2025
Q4 		$625K Hold
77,222
– – ﹤0.01% 2790
2025
Q3 		$1.1M Sell
77,222
-31,424
-29% -$415K ﹤0.01% 2579
2025
Q2 		$1.42M Sell
108,646
-33,515
-24% -$461K ﹤0.01% 2450
2025
Q1 		$2.12M Sell
142,161
-4,750
-3% -$81.6K ﹤0.01% 2318
2024
Q4 		$2.67M Sell
146,911
-4,554
-3% -$61.3K ﹤0.01% 2266
2024
Q3 		$2.04M Sell
151,465
-542
-0.4% -$7.99K ﹤0.01% 2402
2024
Q2 		$2.1M Sell
152,007
-1,440
-0.9% -$22.8K ﹤0.01% 2369
2024
Q1 		$2.87M Sell
153,447
-132,718
-46% -$2.65M ﹤0.01% 2236
2023
Q4 		$6.48M Sell
286,165
-109,860
-28% -$2.38M ﹤0.01% 1831
2023
Q3 		$9.82M Sell
396,025
-5,641
-1% -$142K ﹤0.01% 1496
2023
Q2 		$11.3M Sell
401,666
-72,619
-15% -$1.8M ﹤0.01% 1433
2023
Q1 		$10.6M Sell
474,285
-285,411
-38% -$7.48M ﹤0.01% 1443
2022
Q4 		$20.2M Sell
759,696
-293,342
-28% -$9.57M 0.01% 1037
2022
Q3 		$29.9M Buy
1,053,038
+24,163
+2% +$621K 0.01% 762
2022
Q2 		$21.4M Buy
1,028,875
+199,710
+24% +$3.74M 0.01% 1008
2022
Q1 		$18M Buy
829,165
+484,672
+141% +$10.5M 0.01% 1255
2021
Q4 		$8.51M Sell
344,493
-9,166
-3% -$222K ﹤0.01% 1796
2021
Q3 		$7.36M Buy
353,659
+66,861
+23% +$1.25M ﹤0.01% 1997
2021
Q2 		$4.74M Buy
286,798
+20,071
+8% +$306K ﹤0.01% 2278
2021
Q1 		$3.33M Buy
266,727
+68,400
+34% +$725K ﹤0.01% 2365
2020
Q4 		$1.76M Buy
198,327
+15,407
+8% +$125K ﹤0.01% 2571
2020
Q3 		$1.19M Sell
182,920
-34,553
-16% -$219K ﹤0.01% 2610
2020
Q2 		$1.34M Sell
217,473
-134,679
-38% -$826K ﹤0.01% 2495
2020
Q1 		$2.37M Buy
352,152
+93,786
+36% +$888K ﹤0.01% 2108
2019
Q4 		$3M Buy
258,366
+67,640
+35% +$763K ﹤0.01% 2244
2019
Q3 		$1.96M Sell
190,726
-8,759
-4% -$86.2K ﹤0.01% 2409
2019
Q2 		$1.87M Buy
+199,485
New +$1.54M ﹤0.01% 2471

Other funds holding CCRN

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Nuveen's CCRN Position: Q1 2026 in Review

Nuveen increased its Cross Country Healthcare (CCRN) stake by 32% in Q1 2026, buying an estimated $221K and bringing the position to 101,949 shares worth $958K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

Nuveen first reported a position in CCRN in Q2 2019 and has held it in 28 quarters since. The position peaked at $29.9M in Q3 2022. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.

  • Nuveen held 101,949 shares of Cross Country Healthcare worth $958K as of Q1 2026.
  • Nuveen bought 24,727 Cross Country Healthcare shares in Q1 2026, an estimated $221K.
  • Cross Country Healthcare made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2599 holding.
  • Nuveen first reported a position in Cross Country Healthcare in Q2 2019 and has held it in 28 quarters since.
  • Nuveen's Cross Country Healthcare position peaked at $29.9M in Q3 2022.
  • 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.